The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?

Clinical Microbiology and Infection

Volumn 15, Issue 9, 2009, Pages 865-868

  Debbache, K ^a   Varon, E ^b   Hicheri, Y ^a   Legrand, P ^a   Donay, J L ^c   Ribaud, P ^c   Cordonnier, C ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Hematopoietic stem cell transplantation; Pneumococcal infection

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BRONCHOPNEUMONIA; CEREBROSPINAL FLUID; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; MALE; MYELODYSPLASTIC SYNDROME; MYELOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SEROTYPE; STREPTOCOCCUS PNEUMONIA;

STREPTOCOCCUS PNEUMONIAE;

EID: 69249100565     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02810.x     Document Type: Article

References (27)

1. Kulkarni S, Powles R, Treleaven J et al. Chronic graft versus host disease is associated with long term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 2000; 95: 3683-3686.
2. Engelhard D, Cordonnier C, Shaw PJ et al. Early and late invasive pneumococcal infection following stem cell transplantation: A European Bone Marrow Transplantation survey. Br J Haematol 2002; 117: 444-450.
3. Giebink G, Warkentin P, Ralsay N et al. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients. J Infect Dis 1986; 154: 590-596.
4. Hammarstrom V, Pauksen K, Azinge J, Oberg G LP. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: The influence of graft versus host reaction. Support Care Cancer 1993; 1: 195-199.
5. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 1983; 143: 1735-1737.
6. Avanzini MA, Carra AM, Maccario R et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995; 15: 137-144.
7. Shinefield HR, Black S, Ray P et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis 1999; 18: 757-763.
8. Kumar D, Chen MH, Welsh B et al. A randomized, double blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 2007; 45: 1576-1582.
9. Hausdorff WP, Feikin DR, Kügman KP. Epidemiological differences among pneumococal serotypes. Lancet Infect Dis 2005; 5: 83-93.
10. Scott DA, Komjathy SF, Hu BT et al. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 2007; 25: 6164-6166.
11. Guillemot D, Varon E, Bernède C et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 2005; 41: 930-938.
12. Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Sadfar A. Streptococcus pneumoniae bacteremia in patients with cancer: Disease characteristics and outcomes in the era of escalating drug resistance (1988-2002). Medicine 2005; 84: 303-312.
13. Ljungman P, Engelhard D, Da La Camara R et al. Vaccination of stem cell transplant recipients. Recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737-746.
14. CDC. Guidelines for preventing opportunistic among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49: 1-125.
15. Youssef S, Rodriguez G, Rolston K et al. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections. Medicine 2007; 86: 69-77.
16. Molrine D, Antin JH, Guinan EC et al. Donor immunization with pneumococal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831-836.
17. Meisel R, Kuypers L, Dirksen U et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic stem cell transplantation. Blood 2007; 109: 2322-2326.
18. Cordonnier C, Labopin M, Chesnel V, et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis, in press.
19. Patel SR, Ortin M, Cohen BJ et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae Type B, meningococcus type C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44: 625-634.
20. Antin JH, Guinan EC, Avigan D et al. Protective antibody response to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 213-222.
21. Cherif H, Landgren O, Konradsen HB, Kalin M, Björholm M. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006; 24: 75-81.
22. Safdar A, Rodriguez GH, Rueda AM et al. Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Cancer 2008; 113: 383-387.
23. Schutze GE, Mason EO, Wald ER et al. Pneumococcal infection in children after transplantation. Clin Infect Dis 2001; 33: 16-21.
24. Kumar D, Humar A, Plevneshi A et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: A decade of prospective population-based surveillance. Bone Marrow Transplant 2008; 41: 743-747.
25. Kyaw MH, Lynfield R, Schaffner W et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354: 1455-1463.
26. Albrich WC, Baughman W, Schmotzer B, Farley MM. Changing characteristics of invasive pneumococcal disease in metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal vaccine. Clin Infect Dis 2007; 44: 1569-1576.
27. Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis 2007; 26: 123-128.